Stock listing

F6T Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: F6T · GETTEX · EUR · DE

F6T:GETTEX is the public listing for Fate Therapeutics, Inc., a biotechnology company specializing in innovative cell therapies for cancer and immune disorders. Based in the United States, Fate Therapeutics is committed to enhancing patient outcomes through its proprietary technology platform. The company has been actively involved in advancing its research and development efforts, and its market capitalization is approximately $324 million. Recent news and filings highlight its ongoing progress in the biotechnology sector.